EUCTR2010-020257-13-IT进行中（未招募）不适用
A pilot, prospective, randomized, open, blinded end point, phase II study of tolerability and efficacy of Eperisone in Amyotrophic Lateral Sclerosis - EPERISONE AND ALS
AZIENDA OSPEDALIERO-UNIVERSITARIA0 个研究点开始时间: 2010年7月5日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •In order to be included in this study, patients must meet all of the following criteria: 1. Can provide signed/dated Informed Consent; 2. Are a male or female patient 18-75 years of age; 3. Diagnosis of Amyotrophic Lateral Sclerosis according to EI Escorial Revised Criteria 4. Life expectancy of at least 6 months
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients are excluded from this study if they meet any of the following criteria: 1. Are unable or unwilling to understand study assessment or to cooperate with the study procedures as determined by the investigator 2. any contraindication to the use of eperisone 3. diagnosis of other neurological disease in addition to ALS 4. female subjects pregnant or lactating or plan to become pregnant during the course of the study
研究者
相似试验
进行中（未招募）
1 期
A comparison of two human albumin preparations used in the fluid resuscitation of critically ill adults.Hypovolaemia associated with critical illnessMedDRA version: 19.0 Level: PT Classification code 10038749 Term: Resuscitation System Organ Class: 10042613 - Surgical and medical proceduresEUCTR2016-001940-20-GBCentral Manchester University Hospitals NHS Foundation Trust400
已完成
4 期
Evaluation of intravenous fluid resuscitation with either 4% albumin or 20% albumin solution for patients admitted to the intensive care unitow blood volume statesCritical illnessLow blood volume statesCardiovascular - Other cardiovascular diseasesACTRN12615000349549Austin Health400
进行中（未招募）
1 期
A pilot, unicenter, prospective, aleatorized, with parallel groups, controlled and open to evaluate the efficacy of the Nitric Oxide for Inhalation in the prevention of reperfusion in pulmonary donorpulmonary graft dysfunctionEUCTR2004-004928-12-ESINO Therapeutics AB
尚未招募
4 期
A Pilot, Randomised, Blinded, Feasibility, Safety and Biochemical and Physiological Efficacy Study of Terlipressin vs. Placebo in Cardiac Surgery Patients with the Post-operative High Cardiac Output and Hypotension syndromeACTRN12613001194752Austin Health40
招募中
4 期
A Pilot, Randomised, Blinded, Feasibility, Safety and Biochemical and Physiological Efficacy Study of Terlipressin versus Placebo in Hypotensive SepsisACTRN12613001191785Anaesthesia Intensive Care Trust Fund40